# Solid Power, Inc.: financial statements, quarterly SLDP · Nasdaq · CIK 1844862 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/sldp.md) · [Financials](/companies/sldp/financials.md) · [Filings](/companies/sldp/filings.md) · [Insiders](/companies/sldp/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sldp/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [6.4](/filings/0001558370-24-014938.md) | [2.3 d](/filings/0001558370-25-001874.md) | [6.0](/filings/0001558370-25-006581.md) | [5.1](/filings/0001558370-25-010619.md) | [4.7](/filings/0001104659-25-106583.md) | [4.5 d](/filings/0001104659-26-019435.md) | [5.1](/filings/0001104659-26-055840.md) | [6.5](/filings/0001558370-25-010619.md) | [3.7](/filings/0001104659-25-106583.md) | [2.6 d](/filings/0001104659-26-019435.md) | [2.1](/filings/0001104659-26-055840.md) | [(0.3)](/filings/0001104659-26-090634.md) | | Research and development | $m | [14.2](/filings/0001558370-24-014938.md) | [14.4 d](/filings/0001558370-25-001874.md) | [18.9](/filings/0001558370-25-006581.md) | [18.5](/filings/0001558370-25-010619.md) | [17.3](/filings/0001104659-25-106583.md) | [18.6 d](/filings/0001104659-26-019435.md) | [19.0](/filings/0001104659-26-055840.md) | [18.3](/filings/0001104659-26-090634.md) | [18.3](/filings/0001104659-25-106583.md) | [16.9 d](/filings/0001104659-26-019435.md) | [17.7](/filings/0001104659-26-055840.md) | [19.4](/filings/0001104659-26-090634.md) | | Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating income | $m | [(21.5)](/filings/0001558370-24-014938.md) | [(25.6) d](/filings/0001558370-25-001874.md) | [(25.8)](/filings/0001558370-25-006581.md) | [(26.9)](/filings/0001558370-25-010619.md) | [(27.6)](/filings/0001104659-25-106583.md) | [(25.0) d](/filings/0001104659-26-019435.md) | [(24.0)](/filings/0001104659-26-055840.md) | [(25.9)](/filings/0001104659-26-090634.md) | [(24.4)](/filings/0001104659-25-106583.md) | [(26.5) d](/filings/0001104659-26-019435.md) | [(26.3)](/filings/0001104659-26-055840.md) | [(30.3)](/filings/0001104659-26-090634.md) | | Interest expense | $m | [0.0](/filings/0001558370-23-018110.md) | [0.0 d](/filings/0001558370-24-001906.md) | [0.0](/filings/0001558370-24-007172.md) | [0.0](/filings/0001558370-25-010619.md) | [0.0](/filings/0001104659-25-106583.md) | [0.0 d](/filings/0001104659-26-019435.md) | [0.0](/filings/0001104659-26-055840.md) | [0.0](/filings/0001104659-26-090634.md) | [0.0](/filings/0001104659-25-106583.md) | [0.0 d](/filings/0001104659-26-019435.md) | [0.2](/filings/0001104659-26-055840.md) | [0.0](/filings/0001104659-26-090634.md) | | Income tax | $m | not reported | not reported | not reported | [0.5](/filings/0001558370-25-010619.md) | [0.4](/filings/0001104659-25-106583.md) | [0.3 d](/filings/0001104659-26-019435.md) | not reported | [0.0](/filings/0001104659-26-090634.md) | [0.4](/filings/0001104659-25-106583.md) | [(0.4) d](/filings/0001104659-26-019435.md) | [0.1](/filings/0001104659-26-055840.md) | [(0.1)](/filings/0001104659-26-090634.md) | | Net income | $m | [(15.1)](/filings/0001558370-24-014938.md) | [(19.0) d](/filings/0001558370-25-001874.md) | [(21.2)](/filings/0001104659-25-106583.md) | [(22.3)](/filings/0001104659-25-106583.md) | [(22.4)](/filings/0001104659-25-106583.md) | [(30.6) d](/filings/0001104659-26-019435.md) | [(15.2)](/filings/0001104659-26-090634.md) | [(25.3)](/filings/0001104659-26-090634.md) | [(25.9)](/filings/0001104659-25-106583.md) | [(27.1) d](/filings/0001104659-26-019435.md) | [(13.0)](/filings/0001104659-26-090634.md) | [(23.8)](/filings/0001104659-26-090634.md) | | Diluted EPS | $ per share | [(0.08)](/filings/0001558370-24-014938.md) | not reported | [(0.12)](/filings/0001558370-25-006581.md) | [(0.13)](/filings/0001558370-25-010619.md) | [(0.13)](/filings/0001104659-25-106583.md) | not reported | [(0.08)](/filings/0001104659-26-055840.md) | [(0.14)](/filings/0001104659-26-090634.md) | [(0.14)](/filings/0001104659-25-106583.md) | not reported | [(0.06)](/filings/0001104659-26-055840.md) | [(0.11)](/filings/0001104659-26-090634.md) | | Basic EPS | $ per share | [(0.08)](/filings/0001558370-24-014938.md) | not reported | [(0.12)](/filings/0001558370-25-006581.md) | [(0.13)](/filings/0001558370-25-010619.md) | [(0.13)](/filings/0001104659-25-106583.md) | not reported | [(0.08)](/filings/0001104659-26-055840.md) | [(0.14)](/filings/0001104659-26-090634.md) | [(0.14)](/filings/0001104659-25-106583.md) | not reported | [(0.06)](/filings/0001104659-26-055840.md) | [(0.11)](/filings/0001104659-26-090634.md) | - Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: not reported - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [27.5](/filings/0001558370-23-018110.md) | [34.5](/filings/0001558370-25-001874.md) | [14.0](/filings/0001558370-24-007172.md) | [30.6](/filings/0001558370-24-011190.md) | [38.0](/filings/0001558370-24-014938.md) | [25.4](/filings/0001104659-26-019435.md) | [29.5](/filings/0001558370-25-006581.md) | [26.2](/filings/0001558370-25-010619.md) | [47.3](/filings/0001104659-25-106583.md) | [21.6](/filings/0001104659-26-090634.md) | [31.5](/filings/0001104659-26-055840.md) | [24.3](/filings/0001104659-26-090634.md) | | Current assets | $m | [205](/filings/0001558370-23-018110.md) | [183](/filings/0001558370-25-001874.md) | [171](/filings/0001558370-24-007172.md) | [161](/filings/0001558370-24-011190.md) | [140](/filings/0001558370-24-014938.md) | [125](/filings/0001104659-26-019435.md) | [249](/filings/0001558370-25-006581.md) | [240](/filings/0001558370-25-010619.md) | [262](/filings/0001104659-25-106583.md) | [267](/filings/0001104659-26-090634.md) | [275](/filings/0001104659-26-055840.md) | [251](/filings/0001104659-26-090634.md) | | Total assets | $m | [544](/filings/0001558370-23-018110.md) | [533](/filings/0001558370-25-001874.md) | [516](/filings/0001558370-24-007172.md) | [493](/filings/0001558370-24-011190.md) | [471](/filings/0001558370-24-014938.md) | [448](/filings/0001104659-26-019435.md) | [419](/filings/0001558370-25-006581.md) | [398](/filings/0001558370-25-010619.md) | [416](/filings/0001104659-25-106583.md) | [455](/filings/0001104659-26-090634.md) | [555](/filings/0001104659-26-055840.md) | [527](/filings/0001104659-26-090634.md) | | Current liabilities | $m | [12.0](/filings/0001558370-23-018110.md) | [15.9](/filings/0001558370-25-001874.md) | [18.2](/filings/0001558370-24-007172.md) | [22.9](/filings/0001558370-24-011190.md) | [20.3](/filings/0001558370-24-014938.md) | [20.0](/filings/0001104659-26-019435.md) | [10.4](/filings/0001558370-25-006581.md) | [12.4](/filings/0001558370-25-010619.md) | [16.6](/filings/0001104659-25-106583.md) | [16.8](/filings/0001104659-26-090634.md) | [17.1](/filings/0001104659-26-055840.md) | [17.2](/filings/0001104659-26-090634.md) | | Total liabilities | $m | [26.3](/filings/0001558370-23-018110.md) | [29.5](/filings/0001558370-25-001874.md) | [36.8](/filings/0001558370-24-007172.md) | [35.8](/filings/0001558370-24-011190.md) | [31.4](/filings/0001558370-24-014938.md) | [37.9](/filings/0001104659-26-019435.md) | [22.3](/filings/0001558370-25-006581.md) | [27.2](/filings/0001558370-25-010619.md) | [34.6](/filings/0001104659-25-106583.md) | [38.9](/filings/0001104659-26-090634.md) | [29.3](/filings/0001104659-26-055840.md) | [24.9](/filings/0001104659-26-090634.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [518](/filings/0001558370-24-014938.md) | [503](/filings/0001104659-26-019435.md) | [479](/filings/0001104659-25-106583.md) | [457](/filings/0001104659-25-106583.md) | [439](/filings/0001104659-25-106583.md) | [410](/filings/0001104659-26-090634.md) | [397](/filings/0001104659-26-090634.md) | [371](/filings/0001104659-26-090634.md) | [381](/filings/0001104659-25-106583.md) | [416](/filings/0001104659-26-090634.md) | [525](/filings/0001104659-26-090634.md) | [502](/filings/0001104659-26-090634.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(15.3) d](/filings/0001558370-24-014938.md) | [(6.6) d](/filings/0001558370-25-001874.md) | [(29.1)](/filings/0001558370-25-006581.md) | [(11.1) d](/filings/0001558370-25-010619.md) | [(9.9) d](/filings/0001104659-25-106583.md) | [(13.9) d](/filings/0001104659-26-019435.md) | [(26.3)](/filings/0001104659-26-055840.md) | [(14.4) d](/filings/0001104659-26-090634.md) | [(14.3) d](/filings/0001104659-25-106583.md) | [(18.4) d](/filings/0001104659-26-019435.md) | [(18.8)](/filings/0001104659-26-055840.md) | [(8.4) d](/filings/0001104659-26-090634.md) | | Capital expenditure | $m | [8.3 d](/filings/0001558370-24-014938.md) | [5.0 d](/filings/0001558370-25-001874.md) | [4.1](/filings/0001558370-25-006581.md) | [4.4 d](/filings/0001558370-25-010619.md) | [2.8 d](/filings/0001104659-25-106583.md) | [4.7 d](/filings/0001104659-26-019435.md) | [2.4](/filings/0001104659-26-055840.md) | [2.7 d](/filings/0001104659-26-090634.md) | [0.6 d](/filings/0001104659-25-106583.md) | [4.6 d](/filings/0001104659-26-019435.md) | [1.7](/filings/0001104659-26-055840.md) | [6.3 d](/filings/0001104659-26-090634.md) | | Share repurchases | $m | not reported | not reported | [4.9](/filings/0001558370-25-006581.md) | [3.4](/filings/0001558370-25-010619.md) | [0.0 d](/filings/0001104659-25-106583.md) | [0.8 d](/filings/0001104659-26-019435.md) | not reported | [3.6](/filings/0001104659-26-090634.md) | [0.0 d](/filings/0001104659-25-106583.md) | [0.0 d](/filings/0001104659-26-019435.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [181](/filings/0001104659-26-055840.md) | [180](/filings/0001104659-26-090634.md) | [217](/filings/0001104659-26-055840.md) | [226](/filings/0001104659-26-090634.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 228,181,212 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001104659-26-090634.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.